Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00625742 · ClinicalTrials.gov registry record · NA
Multimodal Treatment Strategy for Cancer Cachexia
A NA study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00625742: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.
NCT00625742 is a NA study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00625742, a NA study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The primary aim of this proposal is to present a novel, multimodal treatment strategy for increasing lean body mass in individuals with cancer who experience cachexia between baseline and day 29 (+/- 3 days). The strategy includes graded resistance training and aerobic exercise, targeted nutrient supplementation and pharmacologic intervention (melatonin). We postulate that this strategy, together with the simultaneous management of symptoms that decrease appetite (e.g. depression, pain, and nausea), will also accomplish our secondary objectives of improving clinical outcomes such as strength and function between baseline and day 29 (+/- 3 days).
Interventions
- BEHAVIORAL Aerobic Exercise
- DRUG Atenolol
- DRUG Melatonin
- DIETARY_SUPPLEMENT Juven
- BEHAVIORAL Graded Resistance Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-02 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00625742
The ClinicalTrials.gov registry entry for NCT00625742 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Aerobic Exercise is the first listed.
NCT00625742 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00625742 about?
NCT00625742 is a clinical study titled "Multimodal Treatment Strategy for Cancer Cachexia". The primary aim of this proposal is to present a novel, multimodal treatment strategy for increasing lean body mass in individuals with cancer who experience cachexia between baseline and day 29 (+/- 3 days). The strategy includes graded resistance training and aerobic exercise, targeted nutrient su...
What is the current status of trial NCT00625742?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2008-02. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00625742?
The interventions under investigation include: Aerobic Exercise (BEHAVIORAL), Atenolol (DRUG), Melatonin (DRUG), Juven (DIETARY_SUPPLEMENT), Graded Resistance Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00625742?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.